Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Haidukon Mar 05, 2020 5:33pm

118 Views

Post# 30772574

RE:Something fishy going on

To my own profound dissatisfaction, I have to agree that there is no independent information confirming thay Hauxipharm is the "Top Chinese Pharmaceutical Development Company" presented in the PR, while I consider that any scenario built on their would be financial ressources (or listing) is purely speculative.

However, I did not reach the conclusion that "something fishy is going on", while so far I do not exclude this possibility.

But nobody cares....

I said what I had to say and will not come back to this subject... I remain fully invested.

Bullboard Posts

Mastering options Greeks: Essential knowledge for informed trading